What is Hansoh Pharmaceutical Group Co OCF Margin %?
Hansoh Pharmaceutical Group CoHNSPF 90 OCF Margin % is 41.25% as of Dec. 2025, which is 45% above its 10-year median of 28.37. GuruFocus rates HNSPF with a GF Score™ of 90/100 and a GF Value™ of $3.00 (Modestly Overvalued). Among 961 Drug Manufacturers companies, Hansoh Pharmaceutical Group Co ranks better than 97.71% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Hansoh Pharmaceutical Group Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hansoh Pharmaceutical Group Co OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hansoh Pharmaceutical Group Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Hansoh Pharmaceutical Group Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hansoh Pharmaceutical Group Co (HNSPF) has a OCF Margin % of 41.25% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Hansoh Pharmaceutical Group Co and its competitors. This is 45% above median its historical median of 28.37. Over the past decade, Hansoh Pharmaceutical Group Co's OCF Margin % has ranged from 22.67 to 44.84. According to the industry distribution chart, Hansoh Pharmaceutical Group Co ranks #22 out of 961 companies in the Drug Manufacturers industry, placing it in the top 2.3%.
Is Hansoh Pharmaceutical Group Co's OCF Margin % too high?
Hansoh Pharmaceutical Group Co's current OCF Margin % of 41.25% is 45% above median its 10-year median of 28.37. Over the past 10 years, this metric has ranged from a low of 22.67 to a high of 44.84. The Drug Manufacturers industry median OCF Margin % is 9.94. Hansoh Pharmaceutical Group Co's value of 41.25% is 315% above this industry median. Based on the distribution chart, Hansoh Pharmaceutical Group Co ranks #22 out of 961 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Hansoh Pharmaceutical Group Co has a GF Score™ of 90/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hansoh Pharmaceutical Group Co's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hansoh Pharmaceutical Group Co ranks #22 out of 961 companies for OCF Margin %. This places Hansoh Pharmaceutical Group Co in the top 2% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.94. Hansoh Pharmaceutical Group Co's value of 41.25% is 315% above this benchmark. Historically, Hansoh Pharmaceutical Group Co's own OCF Margin % has ranged from 22.67 to 44.84 over the past decade. While the company's 10-year median is 28.37 vs. the industry median of 9.94, Hansoh Pharmaceutical Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hansoh Pharmaceutical Group Co's current OCF Margin % of 41.25% is 315% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Hansoh Pharmaceutical Group Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hansoh Pharmaceutical Group Co's current OCF Margin % is 41.25%, which is 45% above median its own 10-year median of 28.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hansoh Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Hansoh Pharmaceutical Group Co (HNSPF) is currently considered Modestly Overvalued. The stock's GF Value™ is $3.00, compared to a current price of $3.83 — trading 27.5% above its estimated fair value. The current OCF Margin % is 41.25%, which is 45% above median its 10-year median of 28.37 and 315% above the Drug Manufacturers industry median of 9.94. Hansoh Pharmaceutical Group Co's overall GF Score™ is 90/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Hansoh Pharmaceutical Group Co (HNSPF), the current OCF Margin % is 41.25% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hansoh Pharmaceutical Group Co (HNSPF) Overvalued in 2026?
Based on GuruFocus' analysis, Hansoh Pharmaceutical Group Co stock appears to be overvalued.
The current stock price of $3.83 is trading 27.5% above its estimated GF Value™ of $3.00.
GuruFocus considers Hansoh Pharmaceutical Group Co to be Modestly Overvalued.
Key valuation signals for HNSPF:
OCF Margin %: 41.25% (45% above median its 10-year median of 28.37)
GF Value™: $3.00 vs. price of $3.83 (27.5% above fair value)
Industry Position: 315% above the Drug Manufacturers median (#22 of 961)
No single metric tells the full story. See the HNSPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hansoh Pharmaceutical Group Co Business Description
Hansoh Pharmaceutical Group Co Ltd is an investment holding company. The company were principally engaged in the research and development, production and sale of a series of pharmaceutical products in the People's Republic of China. It focuses on disease therapeutic areas such as oncology, anti-infectives, CNS, metabolism and immunology. The majority of Group's revenue was generated from the sale of pharmaceutical products in Chinese mainland.
90GF Score
Get the complete analysis for HNSPF
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HNSPF has been successfully added to your 
